Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pathology & Oncology Research
Published in: Pathology & Oncology Research 4/2007

01-12-2007 | Case Report

Genetic alterations of E-cadherin and beta-catenin in germinoma and teratoma: Report of two central nervous system cases

Authors: Nives Pećina-Šlaus, Tamara Niku Eva-Martić, Vili Beroš, Davor Tomas

Published in: Pathology & Oncology Research | Issue 4/2007

Login to get access
Metadata
Title
Genetic alterations of E-cadherin and beta-catenin in germinoma and teratoma: Report of two central nervous system cases
Authors
Nives Pećina-Šlaus
Tamara Niku Eva-Martić
Vili Beroš
Davor Tomas
Publication date
01-12-2007
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 4/2007
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/BF02940319

Other articles of this Issue 4/2007

Pathology & Oncology Research 4/2007 Go to the issue

Article

Prognostic significance of loss of c-fos protein in gastric carcinoma

Article

Histopathological variation of primary mucosa-associated lymphoid tissue lymphoma of the oral cavity

Minireview

Pathology of peripheral neuroblastic tumors: Significance of prominent nucleoli in undifferentiated/poorly differentiated neuroblastoma

Case Report

Rhabdomyomatous mesenchymal hamartoma presenting as a skin tag in the sternoclavicular area

Article

Inappropriate notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes

Article

Expression of the TRAIL receptors in blood mononuclear cells in leukemia
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits